
The new medical device development lab will accommodate the efforts of eight to ten researchers dedicated to developing cutting-edge medical components
“Backed by more than 20 years’ experience providing advanced passive component and interconnect solutions to the medical industry, our new medical device development facility represents an investment of more than $2.1 million and demonstrates our continued commitment to developing state-of-the-art component solutions for life-saving and life-enhancing technologies,” said John Lawing, CTO and vice president of R&D, AVX.
“Our medical design engineers have an innovative approach to problem solving and an in-depth understanding of medical device design requirements, and our quality systems lead the industry and support customer-specific change control, documentation, specification, and testing procedures.”
The company already offers a wide range of advanced tantalum and ceramic capacitors, thin film products, connectors, EMI filters and feedthroughs, SAW filters, and timing devices for medical applications spanning Class III implantable and life-support devices.
AVX – www.avx.com
